FDA Drugs (New Approvals & NDA)Original article
FDA’s Drug Registration and Listing Workshop: Compliance, Regulatory and Submission Updates - 09/29/2026
RegulatoryNeutral
AI Analysis
Summary
FDA will conduct a Drug Registration and Listing Workshop on September 29, 2026, in partnership with SBIA to discuss updates on registration and listing submissions, validation rules, and evolving regulatory requirements.
Importance:1/10
Sentiment:
0.00
FDARegulatoryWorkshopComplianceDrug RegistrationDrug Listing
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 15, 2026 7:05 PM